The company Shiva Pharmachem Limited is coming up with an offer for sale aggregating to INR 900 crores. The promoters of the company plan to sell 10,62,03,000 equity shares for enhancing the brand image and providing liquidity to the existing shareholders.
Shiva Pharmachem Limited IPO – Important Details
| Shiva Pharmachem Limited IPO Date | NA |
| Shiva Pharmachem Limited IPO Listing Date | NA |
| Shiva Pharmachem Limited IPO Price | NA |
| Shiva Pharmachem Limited IPO Lot Size | NA |
| Shiva Pharmachem Limited IPO Total Issue Size | INR 900 crores |
| Shiva Pharmachem Limited IPO Basis of Allotment | NA |
| Shiva Pharmachem Limited IPO Initiation of Refunds | NA |
| Shiva Pharmachem Limited IPO Credit of Shares to Demat | NA |
| Shiva Pharmachem Limited IPO Issue Type | Book Built Issue IPO |
| Shiva Pharmachem Limited IPO Listing At | BSE, NSE |
Shiva Pharmachem Limited IPO – Company Profile
The company is the largest manufacturer of acid and alkyl chlorides, by volume and a key player globally. The company has over 20 years of experience in the Indian specialty chemicals business.
The company’s customer base is diverse, and it served 181 multinational and domestic companies in Fiscal 2023. The company sold its products to 22 countries outside India. In Fiscal 2023, over 80% of the revenue from operations has been generated from Fortune 500 companies globally. Few of the company’s clientele include DuPont Specialty Products USA LLC, Godrej Agrovet Limited, Nouryon Functional Chemicals B.V., Reckitt Benckiser (India) Private Limited, SRF Limited and Syngenta Crop Protection AG.
The Indian facilities are located strategically in India’s chlor-alkali belt in Gujarat, which helps the company to secure an economic supply of chlorine from domestic suppliers.
Shiva Pharmachem Limited IPO Objective
The main objective of the offer is to achieve benefits of listing and to provide liquidity to the existing shareholders. The funds received from the offer for sale will go to the selling shareholders and the company will not receive any funds.
Shiva Pharmachem Limited IPO Risks And Challenges
The company heavily relies on its top 10 customers for around 60% of its revenue, making it vulnerable to losses or reduced purchases from them. Additionally, 81% of revenue comes from international sales, exposing it to global market and regulatory risks. Closure notices from Gujarat Pollution Control board for facilities in Gujarat, contributing 40.18% to revenue, pose uncertainty.
- The company derives almost 60% of the revenue from top 10 customers.Loss of any of these customers or a reduction in purchases by any of them could adversely affect the business, results of operations and financial condition.
- The company is dependent on sales outside of India, which accounted for almost 81% of the revenue. India is subject to international market conditions and foreign regulatory risks that could adversely affect the business, results of operations and financial condition.
- The company in the past has received closure notice from Gujarat Pollution Control board for the manufacturing facilities at Luna and Dahej SEZ in Gujarat. The manufacturing facilities contributed 40.18% to the revenue of the company. There is no assurance that the company will receive permanent revocation of this notice.
Shiva Pharmachem Limited IPO Peer Comparison
| Company | Revenue from operations (₹ in million) | Face Value per Equity Share (₹) | P/E | EPS (Basic) (₹) | EPS (Diluted) (₹) | RoNW (%) | NAV per Equity Share (Basic) (₹) |
| Shiva Pharmachem Limited | 10,794.66 | 2 | – | 10.62 | 10.62 | 20.93% | 50.72 |
| Navin Flourine International Limited | 20,774.00 | 2 | 59.16 | 75.70 | 75.44 | 17.17% | 440.85 |
| Clean Science and Technology Limited | 9,357.99 | 1 | 50.54 | 27.79 | 27.78 | 29.23% | 95.07 |
| Aether Industries Limited | 6,510.74 | 10 | 101.38 | 10.47 | 10.47 | 10.48% | 99.96 |
Shiva Pharmachem Limited IPO Financial Information
| Particular | As at 31 March 2021 | As at 31 March 2022 | As at 31 March 2023 |
| Revenue (₹ in Million) | 7,601.17 | 10,159.90 | 10,794.66 |
| Equity (₹ in Million) | 3,853.93 | 4,664.14 | 5,578.55 |
| Expenses (₹ in Million) | 6,701.17 | 9,198.28 | 9,400.42 |
| Profit and Loss After Tax (₹ in Million) | 851.23 | 892.67 | 1,053.67 |
| RoNW (%) | 22.36% | 18.47% | 20.93% |
| Diluted EPS only (₹) | 7.76 | 7.77 | 10.62 |
| NAV per Equity Share (₹) | 34.71 | 42.09 | 50.27 |
| Total Assets (in million) | 8,532.19 | 10,469.96 | 11,569.37 |
| Total Liabilities (in million) | 4,678.27 | 5,805.83 | 5,990.82 |
Shiva Pharmachem Limited IPO – Industry & Market Potential
The global specialty chemicals market’s growth is being driven by increasing demand for high-performance and function specific chemicals across various end-use industries such as oil and gas, pulp and paper, and personal care and cosmetics. These chemicals are referred to as specialties because they are produced in lesser volumes and cater to only a few applications unlike the rest of the fine and commodity chemicals.
The Indian chemical industry is expected to USD 334 Bn in 2027 at a CAGR of 11%.As multinationals are looking for an alternative to China to avoid further disruptions in supply, India’s chemical industry stands in a favourable spot to profit from this shift and take a sizable share of the market.
Shiva Pharmachem Limited IPO – Type of Offer
Existing shareholders, including promoters and early investors, will sell a portion of their stake in the company worth INR 900 crores.
Shiva Pharmachem Limited IPO Offer Size
Shiva Pharmachem Limited intends to initiate an offer for sale totaling INR 900 crores, where the company’s promoters aim to divest 10,62,03,000 equity shares. This move is intended to boost the company’s reputation and offer liquidity to current shareholders.
Shiva Pharmachem Limited IPO Allotment Structure
In an IPO, shares are allocated as follows: 50% for Qualified Institutional Buyers (QIBs), comprising entities like banks and mutual funds. 15% is for Non-Institutional Investors (NIIs), including corporate bodies and high-value individuals. The remaining 35% goes to Retail Individual Investors (RIIs), who invest smaller amounts.
● Qualified Institutional Buyers (QIB): As per SEBI regulations, 50% of the shares offered through the IPO will be reserved for Qualified Institutional Buyers. These include entities such as banks, mutual funds, and insurance companies.
● Non-Institutional Investors (NII): 15% of the shares will be reserved for Non-Institutional Investors. These typically include corporate bodies or individuals investing more than Rs. 2 lakhs.
● Retail Individual Investors (RII): The remaining 35% of the shares will be allotted to Retail Individual Investors. These individual investors apply for shares with a total value of less than Rs. 2 lakhs.
How to apply for a Shiva Pharmachem Limited IPO?
To apply for the Shiva Pharmachem Limited IPO through Alice Blue, you would typically follow these steps:
1. Open a Demat and Trading Account: If you don’t have one already, you would need to open a Demat and trading account with Alice Blue.
2. Check for IPO Details: Once your account is active, you can check for the Shiva Pharmachem Limited IPO details in the IPO section of the Alice Blue platform.
3. Place the Bid: Enter the number of shares you wish to buy and place your bid within the IPO’s price band.
4. Submit the Application: Confirm all your details and submit your application.
You can apply for the Shiva Pharmachem IPO at Alice Blue in just a few clicks!
Check Allotment Status: Post the allotment process, you can check the allotment status to see if you have received any shares.
Please note that the allotment of shares is not guaranteed and will depend on the demand for the IPO.
How to Check Shiva Pharmachem Limited IPO Allotment Status on Alice Blue?
Checking the allotment status of an IPO in Alice Blue is usually straightforward. Please follow these general steps:
1. Log in to your Alice Blue Account: You can do this through the Alice Blue website or their trading app.
2. Navigate to the Portfolio or IPO Section: This might differ based on the layout of Alice Blue’s platform, but generally, you can find the status of your IPO application under the ‘Portfolio’ or ‘IPO’ section.
3. Find the IPO Allotment Status: Look for a sub-section called ‘IPO Allotment Status’ or something similar. This is where you can see the status of the IPOs you have applied for.
4. Select the Shiva Pharmachem Limited IPO: If you have applied for multiple IPOs, there might be a dropdown menu or a list where you can select the IPO you are interested in. Select the Shiva Pharmachem Limited IPO.
5. Check the Status: The status of your application should be displayed here. If the shares have been allocated to you, it would be mentioned here.
If you face any issues, it’s recommended to contact Alice Blue’s customer support for detailed assistance.
Apart from Alice Blue, there are other ways to check the allotment status of the Shiva Pharmachem Limited IPO:
· Registrar’s Website: Visit the website of Link Intime India Private Limited, the registrar of the Shiva Pharmachem Limited IPO. On the homepage, look for the ‘IPO Allotment Status’ option. You must enter your PAN and application number or Demat account number to check your allotment status. Click on the ‘Submit’ button to view your IPO allotment status.
· NSE and BSE: You can also check the allotment status on the official websites of the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE). You would need your application number and PAN to check the status.
Please note that the allotment status will only be available after the allotment process has been completed, a few days after the IPO window closes.
Asianet Satellite Communications Ltd IPO Offer Registrar
The registrar for the Asianet Satellite Communications IPO is Link Intime India Private Limited. They are responsible for ensuring the IPO allotment and refund processes are carried out smoothly.
Contact information for the registrar:
Link Intime India Private Limited
C-101, 1st Floor, 247 Park
L.B.S. Marg, Vikhroli West
Mumbai – 400 083, Maharashtra
Phone: 022-4918 6200
Email: [email protected]
Website: www.linkintime.co.in
Shiva Pharmachem Limited IPO FAQs
What is the allotment date of the Shiva Pharmachem Limited IPO?
The allotment date is not yet announced by the company.
What is the price band of Shiva Pharmachem Limited IPO?
The price band is not yet announced by the company.
What is the size of the Shiva Pharmachem Limited IPO?
Shiva Pharmachem Limited intends to initiate an offer for sale totaling INR 900 crores, where the company’s promoters aim to divest 10,62,03,000 equity shares. This move is intended to boost the company’s reputation and offer liquidity to current shareholders.
What is the listing date of the Shiva Pharmachem Limited IPO?
The listing date is not yet announced by the company
